3 false false false false false false false false false false true false false false false false false No description of principal activity 2023-09-29 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15174619 2023-09-29 2024-12-31 15174619 2024-12-31 15174619 2023-09-28 15174619 bus:Director1 2023-09-29 2024-12-31 15174619 bus:Director2 2023-09-29 2024-12-31 15174619 bus:Director3 2023-09-29 2024-12-31 15174619 core:WithinOneYear 2024-12-31 15174619 bus:Micro-entities 2023-09-29 2024-12-31 15174619 bus:AuditExemptWithAccountantsReport 2023-09-29 2024-12-31 15174619 bus:SmallCompaniesRegimeForAccounts 2023-09-29 2024-12-31 15174619 bus:PrivateLimitedCompanyLtd 2023-09-29 2024-12-31 15174619 bus:FullAccounts 2023-09-29 2024-12-31
COMPANY REGISTRATION NUMBER: 15174619
PATIENT-CENTRED RESEARCH AND DATA INSIGHTS LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD TO
31 December 2024
PATIENT-CENTRED RESEARCH AND DATA INSIGHTS LTD
STATEMENT OF FINANCIAL POSITION
31 December 2024
Period from
29 Sep 23 to
31 Dec 24
£
Current assets
340
Creditors: amounts falling due within one year
285
-----
Net Current Assets
55
-----
Total Assets Less Current Liabilities
55
Accruals and deferred income
1,200
--------
(1,145)
--------
Capital and reserves
( 1,145)
--------
Notes to the Financial Statements
1. Employee Numbers
The average number of persons employed by the company during the period amounted to 3 .
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 June 2025 , and are signed on behalf of the board by:
M Kramer
Dr K A Finlay
Director
Director
A F Newlands
Director
Company registration number: 15174619
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Halifax House, 30-34 George Street, Hull, Humberside, HU1 3AJ, England.